Demonstrates the creation of Ag@AgCl nanoparticles with unique properties, suggesting their potential in medicinal applications.
Introduction The synthesis of nanomaterials aims to integrate scientific innovation with a commitment to address the UN’s Sustainable Development Goals (SDGs). Our study reports two biotechnological protocols for the synthesis of colloidal Ag@ AgCl nanoparticles (Ag@AgCl-NPs) using the endemic Mauritian herb Psiadia terebinthina via microwave extraction (ME) and heat extraction (HE) methods. Methods The Ag-based nanoparticles (NPs) containing colloids and extracts were tested for antimicrobial, antioxidant, and anti-inflammatory activities. The successful bottom-up phytosynthesis of Ag@AgCl-NPs was characterized by transmission electron microscopy (TEM) with chemical verification using energy-dispersive X-ray spectroscopy (EDS), crystallinity assessment using X-ray diffraction (XRD), UV–VIS and Fourier transform-infrared (FT-IR) spectroscopy, and investigation of colloidal properties. Green synthesis approaches favored NP formation and colloidal stability. Antimicrobial activity was tested against Gram-positive (G+) and Gram-negative (G−) bacteria and fungi using the broth microdilution assay. Antioxidant activity was determined by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method, while anti-inflammatory activity was examined using the bovine serum albumin (BSA) test. Results Our results confirmed the successful green bionanotechnological synthesis of Ag@AgCl-NPs with varying relative mass ratios, exhibiting spherical morphology and good crystallinity. Additionally, both colloids with Ag@AgCl-NPs exhibited exceptional synergistic antimicrobial effects against highly resistant G+ and G− bacterial pathogens and the yeast Candida albicans . They also demonstrated significant anti-inflammatory activity compared to ME or HE extracts, which, surprisingly, showed greater antioxidant activity. Discussion Thus, eco-friendly phytosynthesis from Psiadia terebinthina extracts yielded multifunctional hybrid products with potential utility in pharmacology, medicine, and toxicology.
No takes yet. Share an insight, caveat, or question.
Doongoor et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: